海泰新光收盘上涨2.93%，滚动市盈率39.06倍，总市值56.09亿元

Company Overview - Qindao Haitai Newlight Technology Co., Ltd. specializes in the research, manufacturing, sales, and service of medical endoscope instruments and optical products [1] - The main products include 4K fluorescence/white light laparoscopes, endoscope light source modules, camera adapters, and lenses [1] Financial Performance - For Q1 2025, the company reported a revenue of 147 million yuan, representing a year-on-year increase of 24.86% [1] - The net profit for the same period was 46.69 million yuan, showing a year-on-year growth of 21.45% [1] - The gross profit margin stood at 64.98% [1] Market Position - As of August 20, the closing price of the stock was 46.79 yuan, with a rise of 2.93% [1] - The rolling price-to-earnings (PE) ratio is 39.06, while the industry average PE is 59.32 [1][2] - The total market capitalization of the company is 5.609 billion yuan [1] Institutional Holdings - As of Q1 2025, there are 9 institutions holding shares in Haitai Newlight, all of which are funds, with a total holding of 10.4214 million shares valued at 407 million yuan [1]